Javed Aneeqa, Medina Yelizaveta, Tian Julia, Alvi Muhammad Junaid, Sahra Syeda, Rojas-Marte Geurys
Internal Medicine, Northwell Health, Staten Island, USA.
Cardiology, Northwell Health, Staten Island, USA.
Cureus. 2022 May 8;14(5):e24828. doi: 10.7759/cureus.24828. eCollection 2022 May.
As coronavirus disease 2019 (COVID-19) vaccines are being increasingly administered worldwide, subsequent side effects, such as myocarditis, pericarditis, and myopericarditis, are becoming increasingly more common. Our case describes a 64-year-old male who developed chest pain and shortness of breath one week after receiving the Moderna (Cambridge, Massachusetts) COVID-19 mRNA vaccine. He was found to have a large, left-sided pleural effusion and a small pericardial effusion. The patient underwent thoracentesis and video-assisted thoracoscopic procedure with chest tube placement, which drained bloody pleural and pericardial fluid. He was treated with a course of colchicine. Subsequent imaging revealed the resolution of pericardial and pleural effusions, along with the resolution of symptoms.
随着2019冠状病毒病(COVID-19)疫苗在全球范围内的接种日益增多,随后出现的副作用,如心肌炎、心包炎和心肌心包炎,也越来越常见。我们的病例描述了一名64岁男性,他在接种莫德纳(马萨诸塞州剑桥)COVID-19 mRNA疫苗一周后出现胸痛和呼吸急促。发现他有大量左侧胸腔积液和少量心包积液。患者接受了胸腔穿刺术和胸腔镜辅助手术并放置胸管,引流出血性胸腔和心包积液。他接受了一个疗程的秋水仙碱治疗。随后的影像学检查显示心包和胸腔积液消退,症状也随之缓解。